ClinicalTrials.gg
Not yet recruitingNCT07920874Updated Nov 6, 2026

Financial Tools Access and Navigation (FinTAN)

An interventional study of FinTAN guide in Serious Mental Illness and Financial Hardship, sponsored by Yale University. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Yale University · Not applicable, Interventional, and Supportive care

Updated Nov 6, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The specific aims of this study are to: i) collaboratively create a Financial Tools Access and Navigation (FinTAN) guide to assist persons and care providers to identify the potential utility of relevant financial products, and guide them in their use; ii) pilot test the feasibility and impact of using the FinTAN guide and the associated financial tools and services among people with SMI and those who assist them with their money management; iii) prepare for a future full-scale clinical trial of the FinTAN guide and relevant financial tools and services. The goal for this research project is to create a guide that can assist in creating a Supported Financial Decision Making (SFDM) arrangements, whereby persons with SMI can access the support they need with their finances while maximizing autonomy and flexibility over time.

Read the detailed description

Financial hardship and mental illness intersect in ways that have devastating consequences for millions of American. Financial hardship among people with SMI arises partly from meager disability benefits and/or low wages but is exacerbated when people have difficulty managing money due to their illness. This project will test an intervention that will guide people through the use of financial tools and services that may allow people to more effectively manage their own finances, receive assistance from another person in a way that maximizes that autonomy of the owner of the funds, and that offer pathways towards greater autonomy over time, so improving mental health and quality of life.

The research for this pilot will engage with a Community Advisory Board (CAB) to inform the FinTAN guide intervention and data collection instruments in order to finalize the research design for this pilot and a future randomized trial.

Nov 2026: Secondary outcomes are still being finalized with the Community Advisory Board.

02

Conditions studied

  • Serious Mental Illness
  • Financial Hardship

Keywords

  • Financial Health
  • Mental Health
03

In context

Financial Stress

100 studies on the registry are indexed under Financial Stress; 34 are open to participants now.

This study's planned enrollment of 60 is below the median of 96 across 61 interventional studies indexed under Financial Stress.

Browse Financial Stress studies →

Lead sponsor

Yale University is the lead sponsor of 1,770 studies on the registry; 294 are open to participants now.

Of its 221 completed or terminated interventional studies of FDA-regulated products, 129 (58%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 years of age or older who are using services at the Connecticut Mental Health Center
  • Self-identify as having money management challenges
  • Provide services at the community mental health center
  • Provide financial management support to people who have SMI

Exclusion criteria

Exclusion Criteria:

  • Vulnerable populations will not be recruited (ie prisoners, pregnant women, decisionally impaired).
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    FinTAN for participants with SMI

    Participants in this arm will receive the FinTAN guide

    Behavioral: FinTAN guide

Interventions

  • BehavioralFinTAN guide

    FinTAN guide to assist participants and care providers to identify the potential utility of relevant financial products, and guide them in their use

06

What researchers measure

Primary outcomes

  1. Mean score Financial Self-Efficacy Scale

    6 statements evaluating personal financial confidence and management. Score ranges from 6 to 24, where higher scores mean greater financial self-efficacy.

    Time frame: Day 1, Day 90 ±7, Day 180 ±7, Day 360 ±7, Day 540 ±7

07

Study locations

1 site
  • Connecticut Mental Health Center (CMHC) Program for Recovery and Community Health
    New Haven, Connecticut 06513, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07920874
Lead sponsor
Yale University
Responsible party
Sponsor
First posted
Nov 6, 2026
Start date
Dec 2026 (estimated)
Primary completion
May 2028 (estimated)
Completion
May 2028 (estimated)
Last update
Nov 6, 2026

Study contacts

Annie Harper, PhD
Contact
Annie.harper@yale.edu
203-764-8602
Annie Harper, PhD
principal investigator · Yale University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion